Moderate

Secondary hypertension — evaluation & workup

Identifiable cause screen · Cardiac
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Secondary hypertension is raised BP from an identifiable cause, found in ~10% of hypertensives. Clues include young onset, resistant or accelerated hypertension, hypokalaemia, or clinical features of an endocrine or renal disorder; targeted testing can yield curable causes.

Red flags

  • Paroxysmal headache, palpitations and sweating (phaeochromocytoma)
  • Flash pulmonary oedema with preserved LV function (bilateral renal artery stenosis)
  • Spontaneous or diuretic-induced hypokalaemia
  • Hypertension with abdominal or flank bruit
  • Accelerated hypertension in a patient under 40

Assessment

Differential diagnosis

  • Primary aldosteronism (Conn)
  • Renal artery stenosis / renovascular
  • Chronic kidney disease
  • Phaeochromocytoma/paraganglioma
  • Obstructive sleep apnoea
  • Cushing syndrome
  • Aortic coarctation / thyroid disease

Investigations

  • Plasma aldosterone-to-renin ratio (off interfering drugs)
  • U&E with attention to hypokalaemia and renal function
  • Renal artery imaging (duplex, CT or MR angiography)
  • Plasma free metanephrines or 24h urinary metanephrines
  • Overnight dexamethasone suppression or late-night salivary cortisol
  • TFTs, and sleep study if OSA suspected

Management

  • Identify red-flag features prompting workup: young age, resistant, accelerated, hypokalaemia
  • Stop or account for drugs affecting the aldosterone-renin ratio where feasible
  • Measure aldosterone-to-renin ratio as first-line screen for primary aldosteronism
  • Assess renal function and urinalysis for intrinsic renal disease
  • Image renal arteries if bruit, flash pulmonary oedema or rising creatinine on ACEi
  • Screen for phaeochromocytoma with plasma/urinary metanephrines if paroxysmal symptoms
  • Screen for Cushing with dexamethasone suppression if phenotype present
  • Evaluate for OSA with validated questionnaire and polysomnography
  • Measure four-limb BP and image aorta if coarctation suspected
  • Refer confirmed endocrine causes for confirmatory testing and subtyping
  • Treat the underlying cause and continue antihypertensives as needed
  • Avoid over-investigation in older patients with classic essential hypertension

Drugs & doses

Spironolactone 25-50 mg PO OD (aldosteronism, while awaiting intervention)
Phenoxybenzamine 10 mg PO BD titrated (alpha blockade before pheochromocytoma surgery)
Doxazosin MR 4-8 mg PO OD (alternative alpha blockade)
Amlodipine 5-10 mg PO OD (non-interfering agent during ARR testing)
Verapamil SR 120-240 mg PO OD (non-interfering agent during ARR testing)

Disposition

Refer to hypertension specialist, endocrinology or nephrology depending on cause. Surgical referral for adenoma, stenosis or coarctation as indicated.

Complications & pitfalls

  • Hypertensive emergency / target-organ damage
  • Hypertensive crisis during pheochromocytoma manipulation
  • Progressive renal impairment
  • Stroke and cardiovascular events
  • Delayed diagnosis of curable cause

Exam pearls

  • Never give a beta-blocker before alpha blockade in phaeochromocytoma
  • A low or suppressed renin with high aldosterone suggests primary aldosteronism
  • ACEi-induced acute kidney injury flags bilateral renal artery stenosis
  • Primary aldosteronism is far more common than historically taught — screen liberally
  • Confirm positive screens before committing to surgery or lifelong therapy

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.